Pure Global AI
NCT06355687Not yet recruiting

Melatonin in Obese Patients in Laparoscopic Cholecystectomy

The Evaluation of Adding Melatonin to Opioid Free Anesthesia on Postoperative Pain in Obese Patients Undergoing Laparoscopic Cholecystectomy
Ain Shams UniversityClinicalTrials.govdrug
Verified
Study focus
Disease/Condition
Anesthesia
Drug/Device/Intervention
Melatonin
Study type
Interventional
Intervention type
drug
Sponsor & location
Primary sponsor
Ain Shams University
Timeline & enrollment
Phase
N/A
Start date
Apr 01, 2024
End date
Apr 01, 2025
Enrollment
60 participants
Primary outcome

Postoperative Pain.

Summary

Opioid free anesthesia (OFA) means a technique in which no intraoperative opioid is
 administered through any route. Perioperative pain management in an obese patient is
 challenging. The incidence of respiratory depression is higher in obese patients and is
 exaggerated with opioids, so the investigators are searching for a drug that has analgesic
 effect without any effect on respiratory function. In this study, the investigators will add
 melatonin to OFA in obese patients undergoing laparoscopic cholecystectomy.

ICD-10 classifications
Anaesthetic, unspecifiedOther and unspecified general anaestheticsLocal anaestheticsOther complications of anaesthesiaComplication of anaesthesia during labour and delivery, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06355687
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06355687 through Pure Global AI's free database. This phase not specified trial is sponsored by Ain Shams University and is currently Not yet recruiting. The study focuses on Anesthesia. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.